This report aims to provide a comprehensive presentation of the global market for Cannabinoid-based Products for Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabinoid-based Products for Cancer. This report contains market size and forecasts of Cannabinoid-based Products for Cancer in global, including the following market information:
Global Cannabinoid-based Products for Cancer Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cannabinoid-based Products for Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Smoking Products Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cannabinoid-based Products for Cancer include Bausch Health, GW Pharmaceuticals, Cannabics Inc., Tikun Olam and Jay Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cannabinoid-based Products for Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cannabinoid-based Products for Cancer Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cannabinoid-based Products for Cancer Market Segment Percentages, by Type, 2022 (%)
Smoking Products
Food Products
Oil
Coat Product
Other
Global Cannabinoid-based Products for Cancer Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cannabinoid-based Products for Cancer Market Segment Percentages, by Application, 2022 (%)
Clinics
Hospitals
Others
Global Cannabinoid-based Products for Cancer Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cannabinoid-based Products for Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cannabinoid-based Products for Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cannabinoid-based Products for Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health
GW Pharmaceuticals
Cannabics Inc.
Tikun Olam
Jay Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cannabinoid-based Products for Cancer, market overview.
Chapter 2: Global Cannabinoid-based Products for Cancer market size in revenue.
Chapter 3: Detailed analysis of Cannabinoid-based Products for Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cannabinoid-based Products for Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cannabinoid-based Products for Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cannabinoid-based Products for Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cannabinoid-based Products for Cancer Overall Market Size
2.1 Global Cannabinoid-based Products for Cancer Market Size: 2022 VS 2030
2.2 Global Cannabinoid-based Products for Cancer Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cannabinoid-based Products for Cancer Players in Global Market
3.2 Top Global Cannabinoid-based Products for Cancer Companies Ranked by Revenue
3.3 Global Cannabinoid-based Products for Cancer Revenue by Companies
3.4 Top 3 and Top 5 Cannabinoid-based Products for Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cannabinoid-based Products for Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cannabinoid-based Products for Cancer Players in Global Market
3.6.1 List of Global Tier 1 Cannabinoid-based Products for Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Cannabinoid-based Products for Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cannabinoid-based Products for Cancer Market Size Markets, 2022 & 2030
4.1.2 Smoking Products
4.1.3 Food Products
4.1.4 Oil
4.1.5 Coat Product
4.1.6 Other
4.2 By Type - Global Cannabinoid-based Products for Cancer Revenue & Forecasts
4.2.1 By Type - Global Cannabinoid-based Products for Cancer Revenue, 2018-2023
4.2.2 By Type - Global Cannabinoid-based Products for Cancer Revenue, 2024-2030
4.2.3 By Type - Global Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cannabinoid-based Products for Cancer Market Size, 2022 & 2030
5.1.2 Clinics
5.1.3 Hospitals
5.1.4 Others
5.2 By Application - Global Cannabinoid-based Products for Cancer Revenue & Forecasts
5.2.1 By Application - Global Cannabinoid-based Products for Cancer Revenue, 2018-2023
5.2.2 By Application - Global Cannabinoid-based Products for Cancer Revenue, 2024-2030
5.2.3 By Application - Global Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cannabinoid-based Products for Cancer Market Size, 2022 & 2030
6.2 By Region - Global Cannabinoid-based Products for Cancer Revenue & Forecasts
6.2.1 By Region - Global Cannabinoid-based Products for Cancer Revenue, 2018-2023
6.2.2 By Region - Global Cannabinoid-based Products for Cancer Revenue, 2024-2030
6.2.3 By Region - Global Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cannabinoid-based Products for Cancer Revenue, 2018-2030
6.3.2 US Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.3.3 Canada Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.3.4 Mexico Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cannabinoid-based Products for Cancer Revenue, 2018-2030
6.4.2 Germany Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.4.3 France Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.4.4 U.K. Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.4.5 Italy Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.4.6 Russia Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.4.7 Nordic Countries Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.4.8 Benelux Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cannabinoid-based Products for Cancer Revenue, 2018-2030
6.5.2 China Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.5.3 Japan Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.5.4 South Korea Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.5.5 Southeast Asia Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.5.6 India Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cannabinoid-based Products for Cancer Revenue, 2018-2030
6.6.2 Brazil Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.6.3 Argentina Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cannabinoid-based Products for Cancer Revenue, 2018-2030
6.7.2 Turkey Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.7.3 Israel Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.7.4 Saudi Arabia Cannabinoid-based Products for Cancer Market Size, 2018-2030
6.7.5 UAE Cannabinoid-based Products for Cancer Market Size, 2018-2030
7 Cannabinoid-based Products for Cancer Companies Profiles
7.1 Bausch Health
7.1.1 Bausch Health Company Summary
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Cannabinoid-based Products for Cancer Major Product Offerings
7.1.4 Bausch Health Cannabinoid-based Products for Cancer Revenue in Global Market (2018-2023)
7.1.5 Bausch Health Key News & Latest Developments
7.2 GW Pharmaceuticals
7.2.1 GW Pharmaceuticals Company Summary
7.2.2 GW Pharmaceuticals Business Overview
7.2.3 GW Pharmaceuticals Cannabinoid-based Products for Cancer Major Product Offerings
7.2.4 GW Pharmaceuticals Cannabinoid-based Products for Cancer Revenue in Global Market (2018-2023)
7.2.5 GW Pharmaceuticals Key News & Latest Developments
7.3 Cannabics Inc.
7.3.1 Cannabics Inc. Company Summary
7.3.2 Cannabics Inc. Business Overview
7.3.3 Cannabics Inc. Cannabinoid-based Products for Cancer Major Product Offerings
7.3.4 Cannabics Inc. Cannabinoid-based Products for Cancer Revenue in Global Market (2018-2023)
7.3.5 Cannabics Inc. Key News & Latest Developments
7.4 Tikun Olam
7.4.1 Tikun Olam Company Summary
7.4.2 Tikun Olam Business Overview
7.4.3 Tikun Olam Cannabinoid-based Products for Cancer Major Product Offerings
7.4.4 Tikun Olam Cannabinoid-based Products for Cancer Revenue in Global Market (2018-2023)
7.4.5 Tikun Olam Key News & Latest Developments
7.5 Jay Pharma
7.5.1 Jay Pharma Company Summary
7.5.2 Jay Pharma Business Overview
7.5.3 Jay Pharma Cannabinoid-based Products for Cancer Major Product Offerings
7.5.4 Jay Pharma Cannabinoid-based Products for Cancer Revenue in Global Market (2018-2023)
7.5.5 Jay Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cannabinoid-based Products for Cancer Market Opportunities & Trends in Global Market
Table 2. Cannabinoid-based Products for Cancer Market Drivers in Global Market
Table 3. Cannabinoid-based Products for Cancer Market Restraints in Global Market
Table 4. Key Players of Cannabinoid-based Products for Cancer in Global Market
Table 5. Top Cannabinoid-based Products for Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cannabinoid-based Products for Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cannabinoid-based Products for Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cannabinoid-based Products for Cancer Product Type
Table 9. List of Global Tier 1 Cannabinoid-based Products for Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cannabinoid-based Products for Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cannabinoid-based Products for Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cannabinoid-based Products for Cancer Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cannabinoid-based Products for Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cannabinoid-based Products for Cancer Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cannabinoid-based Products for Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cannabinoid-based Products for Cancer Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2024-2030
Table 30. Bausch Health Company Summary
Table 31. Bausch Health Cannabinoid-based Products for Cancer Product Offerings
Table 32. Bausch Health Cannabinoid-based Products for Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Bausch Health Key News & Latest Developments
Table 34. GW Pharmaceuticals Company Summary
Table 35. GW Pharmaceuticals Cannabinoid-based Products for Cancer Product Offerings
Table 36. GW Pharmaceuticals Cannabinoid-based Products for Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. GW Pharmaceuticals Key News & Latest Developments
Table 38. Cannabics Inc. Company Summary
Table 39. Cannabics Inc. Cannabinoid-based Products for Cancer Product Offerings
Table 40. Cannabics Inc. Cannabinoid-based Products for Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. Cannabics Inc. Key News & Latest Developments
Table 42. Tikun Olam Company Summary
Table 43. Tikun Olam Cannabinoid-based Products for Cancer Product Offerings
Table 44. Tikun Olam Cannabinoid-based Products for Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. Tikun Olam Key News & Latest Developments
Table 46. Jay Pharma Company Summary
Table 47. Jay Pharma Cannabinoid-based Products for Cancer Product Offerings
Table 48. Jay Pharma Cannabinoid-based Products for Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Jay Pharma Key News & Latest Developments
List of Figures
Figure 1. Cannabinoid-based Products for Cancer Segment by Type in 2022
Figure 2. Cannabinoid-based Products for Cancer Segment by Application in 2022
Figure 3. Global Cannabinoid-based Products for Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cannabinoid-based Products for Cancer Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cannabinoid-based Products for Cancer Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cannabinoid-based Products for Cancer Revenue in 2022
Figure 8. By Type - Global Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
Figure 16. US Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
Figure 20. Germany Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 21. France Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
Figure 28. China Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 32. India Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
Figure 34. Brazil Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cannabinoid-based Products for Cancer Revenue Market Share, 2018-2030
Figure 37. Turkey Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cannabinoid-based Products for Cancer Revenue, (US$, Mn), 2018-2030
Figure 41. Bausch Health Cannabinoid-based Products for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GW Pharmaceuticals Cannabinoid-based Products for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Cannabics Inc. Cannabinoid-based Products for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Tikun Olam Cannabinoid-based Products for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Jay Pharma Cannabinoid-based Products for Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
